Pass on the Pink Pill
Flibanserin (brand name: Addyi) is the first drug approved by the U.S. Food and Drug Administration (FDA) to treat lack of sexual desire (Hypoactive Sexual Desire Disorder) in premenopausal women.
FOR IMMEDIATE RELEASE
Contact: Shaniqua Seth at [email protected] or 202.682-2640, ext. 225
Click image to download PDF of the report card. Report Card References 1 – Addyi’s FDA Warning Addyi’s life-threatening side effects were so grave that they warranted the strictest possible warning by the FDA—a “black box warning.” Those side effects…
FOR IMMEDIATE RELEASE
Contact: Nora Brodnitz at [email protected] or 202-471-0043
FOR IMMEDIATE RELEASE
To schedule an interview with Cindy Pearson contact: Sarah Courtney at [email protected] or 917-913-1994
FOR IMMEDIATE RELEASE
To schedule an interview with Cindy Pearson and Susan Wood, contact Sarah Courtney at [email protected] or 917-913-1994